- Home
- GRABW vs GALT Comparison
GRABW vs GALT Comparison
Compare GRABW & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- GALT
- Stock Information
- Founded
- GRABW 2012
- GALT 2000
- Country
- GRABW Singapore
- GALT United States
- Employees
- GRABW 11267
- GALT N/A
- Industry
- GRABW Business Services
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- GALT Health Care
- Exchange
- GRABW Nasdaq
- GALT Nasdaq
- Market Cap
- GRABW N/A
- GALT 83.5M
- IPO Year
- GRABW N/A
- GALT N/A
- Fundamental
- Price
- GRABW $0.39
- GALT $2.45
- Analyst Decision
- GRABW
- GALT Buy
- Analyst Count
- GRABW 0
- GALT 2
- Target Price
- GRABW N/A
- GALT $6.00
- AVG Volume (30 Days)
- GRABW 54.7K
- GALT 1.4M
- Earning Date
- GRABW 02-21-2025
- GALT 08-12-2025
- Dividend Yield
- GRABW N/A
- GALT N/A
- EPS Growth
- GRABW N/A
- GALT N/A
- EPS
- GRABW N/A
- GALT N/A
- Revenue
- GRABW $2,686,000,000.00
- GALT N/A
- Revenue This Year
- GRABW N/A
- GALT N/A
- Revenue Next Year
- GRABW N/A
- GALT N/A
- P/E Ratio
- GRABW N/A
- GALT N/A
- Revenue Growth
- GRABW 21.65
- GALT N/A
- 52 Week Low
- GRABW $0.15
- GALT $0.73
- 52 Week High
- GRABW $0.59
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- GRABW 38.64
- GALT 61.39
- Support Level
- GRABW $0.33
- GALT $2.21
- Resistance Level
- GRABW $0.37
- GALT $3.90
- Average True Range (ATR)
- GRABW 0.03
- GALT 0.47
- MACD
- GRABW -0.00
- GALT 0.09
- Stochastic Oscillator
- GRABW 8.33
- GALT 40.84
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.